Published in Transplant Proc on March 01, 2005
Prognosis in HIV-infected patients with non-small cell lung cancer. Br J Cancer (2013) 0.92
JC virus infection in colorectal neoplasia that develops after liver transplantation. Clin Cancer Res (2008) 0.85
Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients. Transplantation (2015) 0.79
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77
Alcoholic liver disease is a strong predictor of colorectal polyps in liver transplant recipients. Endosc Int Open (2017) 0.75
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
Prospective iterative trial of proteasome inhibitor-based desensitization. Am J Transplant (2015) 1.72
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am J Transplant (2011) 1.69
Ethics of a paired-kidney-exchange program. N Engl J Med (1997) 1.66
Increased utilization of organ donors: transplantation of two recipients from single donor livers. Transplant Proc (1990) 1.61
Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant (2011) 1.59
Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5-15 micrograms/ml. Pharmacotherapy (1994) 1.39
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant (2010) 1.31
Portal vein thrombosis and stenosis in pediatric liver transplantation. Transplantation (1996) 1.27
FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation (1997) 1.26
Immunosuppression and Merkel cell cancer. Transplant Proc (2002) 1.25
The effect of early versus late fasciotomy in the management of extremity trauma. Surgery (1997) 1.17
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc (2005) 1.17
Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant (2006) 1.16
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation (1996) 1.14
Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant (2009) 1.11
The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (2000) 1.09
Complications in 100 living-liver donors. Ann Surg (1998) 1.07
Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation (2000) 1.03
Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients. Ann Surg (2000) 1.01
Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation (1995) 1.01
Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int (1996) 0.99
Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant (2013) 0.97
The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96
Biliary complications in living donor liver transplantation. Transplant Proc (1997) 0.95
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. Transplantation (2001) 0.94
Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med (1985) 0.94
Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc (2005) 0.93
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc (2005) 0.92
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc (1998) 0.91
Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol (1994) 0.91
Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions. Transplantation (1996) 0.91
Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results. Am J Transplant (2013) 0.90
Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol (1998) 0.90
The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol (1999) 0.89
Orthotopic liver transplantation in a patient with Amanita poisoning. JAMA (1985) 0.88
The evidence for single-incision laparoscopic colectomy: is it time to adopt? Minerva Chir (2012) 0.88
Laparoscopic living donor nephrectomy for kidneys with multiple arteries. Transplant Proc (2005) 0.88
Evolving experience of hepatitis B virus prophylaxis in liver transplantation. Transpl Infect Dis (2002) 0.87
Are concerns over right laparoscopic donor nephrectomy unwarranted? Ann Surg (2001) 0.87
Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc (2005) 0.87
Helical CT examination of potential kidney donors. AJR Am J Roentgenol (1998) 0.87
Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis (1999) 0.86
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation (1998) 0.86
Incompatible kidney donor candidates' willingness to participate in donor-exchange and non-directed donation. Am J Transplant (2006) 0.86
Laparoscopic right living donor nephrectomy. Transplant Proc (2005) 0.85
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy. Transplant Proc (2002) 0.85
Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc (2002) 0.85
Primum non nocere: avoiding harm to vulnerable wait list candidates in an indirect kidney exchange. Transplantation (2001) 0.84
Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs. Transplantation (2000) 0.84
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery (2001) 0.84
Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. Ann Surg (1999) 0.84
Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Transplantation (1994) 0.84
De novo breast cancer in renal transplant recipients. Transplant Proc (2002) 0.84
Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin. J Nucl Med (1989) 0.83
Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis (2003) 0.83
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis (2001) 0.83
Proteasome inhibition reduces donor-specific antibody levels. Transplant Proc (2009) 0.82
A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years. Transplant Proc (2005) 0.82
Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago. Transpl Int (1994) 0.82
Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy. Am J Transplant (2015) 0.81
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc (2005) 0.81
Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc (2005) 0.81
Human granulocytic ehrlichiosis in pancreas transplant recipients. Transpl Infect Dis (2001) 0.81
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. Clin Transplant (2013) 0.81
Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation (1990) 0.81
Inhibition of gastric cancer by camptothecin involves apoptosis and multiple cellular pathways. Surgery (1999) 0.80
Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc (2005) 0.80
Proteasome inhibitor therapy for antibody-mediated rejection. Pediatr Transplant (2011) 0.80
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. Transplantation (2001) 0.80
Immunosuppression, generic drugs and the FDA. Am J Transplant (2011) 0.80
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc (2005) 0.80
Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc (1998) 0.80
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival. Transplant Proc (2001) 0.80